Free Press Release

FaceBook Page Twitter Feed
 
You are here: Home > Exclusive News > Health Point Inc. Continues Planning for IPO

Health Point Inc. Continues Planning for IPO


Posted May 21, 2014 by reginaldanderson
Health Point Inc. is looking to fund capacity building expansions through a highly anticipated IPO later this year.
 

FOR IMMEDIATE RELEASE

Pressnews.biz (Press Release) May 21, 2014 -- Researchers around the globe are continuing to turn to Health Point Inc's important stem cell research and related products for their own work. Demand has already outpaced the production capacity of the recently expanded facilities.

As a leader in the provision of hematological samples to the research community, Health Point Inc. has over two decades of experience in performing hematopoietic stem cell assays. Numerous important health research projects and clinical studies around the world rely on the cell assays performed by Health Point Inc.

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at healthpointincorporated.com.

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this release is provided on an errors and omissions accepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at healthpointincorporated.com and other sources before making any material decisions.
-- EOF ---
Contact Email : p...@healthpointincorporated.com
Issued By : Reginald Anderson
Phone : 85281930750
Business Address : 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central, Hong Kong
Country : China
Categories : Business
Tags : health, Stem Cells, Research, Manufacture, Supply, Investment
Last Updated : May 21, 2014

New Press News

blog comments powered by Disqus
Popular TagsMore
CategoriesMore
CountriesMore